News

- Novartis Invests USD 140m in Pharmaceutical Plant in St. Petersburg
- Akrikhin Expanded its Portfolio by New Neurological Medicine
- Dalchempharm's Net Profit Rose 20.3% for 2011
- Valeant Pharmaceuticals Agrees to Acquire Natur Produkt in Russia
- Biofarma Earns USD 1.5m in 2011
- Borshchahivka Chemical and Pharmaceutical Plant Increased Net Revenues for January-March 2012
- Darnitsa Pharmaceutical Firm Ends 2011 in the Black
- Vinnytsiapharmacia Finishes 2011 in the Black
- Biokon Ends 2011 with Profit of USD 825,780
- Lubnypharm Ends 2011 with Profit of USD 487,960
- Farmacia Ends 2011 with Profit of USD 212,700
- Stirolbiopharm Earns USD 1.07m of Pre-Tax Profit in Q1, 2012
- Ukrainian Pharmaceutical Companies Announced Update on Net Revenues
- Sopharma Decides to Create Sopharma Ukraine Subsidiary
- Ukrainian Cabinet Approves of Transfer of Powers for Medications Quality and Safety Control to Pharmaceuticals Service
- Bangladeshi Pharmaceiticals to Enter Custom Union Market through Belarusian Door
- Pharmaceutical Boom in Kazakhstan in Q1, 2012
- Georgian Pharmaceuticals Production Increased 35% in 2011
- Ropharma Plans to Expand Output of its Drugs to 10% until 2015
- Ranbaxy Laboratories and Daiichi Sankyo to Start Production of Hypertension Drug in Romania
- Romanian Pharma Producers Worried by Current Clawback Tax

© Eurasian chemical market, 2005-2023